Psychiatry might need some psychedelic therapy

References

• Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P.C.R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of Psychopharmacology, 29, 289–299. doi:10.1177/0269881114565144
   PubMed Web of Science ®Google Scholar
• Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30, 1268–1278. doi:10.1177/0269881116662634
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C.M.J., Erritzoe, D., Kaelen, M., … Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3, 619–627. doi:10.1016/S2215-0366(16)30065-7
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., … Nutt, D. J. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proceedings of the National Academy of Sciences, 109, 2138–2143. doi:10.1073/pnas.1119598109
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., … Nutt, D. J. (2017). Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports, 7, 13187. doi:10.1038/s41598-017-13282-7
   PubMed Web of Science ®Google Scholar
• Case, A., & Deaton, A. (2015). Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences, 112, 15078–15083. doi:10.1073/pnas.1518393112
   PubMed Web of Science ®Google Scholar
• Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., … Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 391, 1357–1366. doi:10.1016/S0140-6736(17)32802-7
   PubMed Web of Science ®Google Scholar
• Darwin, C. R. (1859). On the origin of species by means of natural selection, or the preservation of favoured races in the struggle for life. London: John Murray.
   Google Scholar
• Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and efficacy of LSD-assisted psychotherapy in subjects with anxiety associated with life-threatening diseases: a randomized active placebo-controlled phase 2 pilot study. Journal Nervous and Mental Disease, 202, 513–520. doi:10.1097/NMD.0000000000000113
   PubMed Web of Science ®Google Scholar
• Glennon, R. A., Titeler, M., & McKenney, J. D. (1984). Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences, 35, 2505–2511. doi:10.1016/0024-3205(84)90436-3
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., … Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30, 1181–1197. doi:10.1177/0269881116675513
   PubMed Web of Science ®Google Scholar
• Grinspoon, L. (1981). LSD Reconsidered. The Sciences, 21, 20–23. doi:10.1002/j.2326-1951.1981.tb01901.x
   Google Scholar
• Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68, 71–78. doi:10.1001/archgenpsychiatry.2010.116
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Clark, C. B., Johnson, M. W., Fontaine, K. R., & Cropsey, K. L. (2014). Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology, 28, 62–66. doi:10.1177/0269881113513851
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Johnson, M. W., & Griffiths, R. R. (2015). Psilocybin, psychological distress, and suicidality. Journal of Psychopharmacology, 29, 1041–1043. doi:10.1177/0269881115598338
   PubMed Web of Science ®Google Scholar
• Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29, 280–288. doi:10.1177/0269881114565653
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28, 983–992. doi:10.1177/0269881114548296
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017). Long-term follow-up of psilocybin-facilitated smoking cessation. The American Journal of Drug and Alcohol Abuse, 43, 55–60. doi:10.3109/00952990.2016.1170135
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., & Griffiths, R. R. (2017). Potential therapeutic effects of psilocybin. Neurotherapeutics, 14, 734–740. doi:10.1007/s13311-017-0542-y
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018). The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology. doi:10.1016/j.neuropharm.2018.05.012
   Google Scholar
• Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22, 603–620. doi:10.1177/0269881108093587
   PubMed Web of Science ®Google Scholar
• Kolar, D. (2018). Addictive potential of novel treatments for refractory depression and anxiety. Neuropsychiatric Disease and Treatment, 14, 1513. doi:10.2147/NDT.S167538
   PubMed Web of Science ®Google Scholar
• Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559–574. doi:10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Kuhn, T. S. (1962). The structure of scientific revolutions (3rd ed.). Chicago: The University of Chicago Press.
   Google Scholar
• McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association, 284, 1689–1695. doi:10.1001/jama.284.13.1689
   PubMed Web of Science ®Google Scholar
• Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., & Meana, J. J. (2018). Antidepressant efficacy and tolerability of ketamine and esketamine: A critical review. CNS Drugs, 32, 411–420. doi:10.1007/s40263-018-0519-3
   PubMed Web of Science ®Google Scholar
• Newton, I. (1687). Philosophiae naturalis principia mathematica. E. Halley (ed.). London: Joseph Streater for the Royal Society.
   Google Scholar
• Nichols, D. E., Johnson, M. W., & Nichols, C. D. (2017). Psychedelics as medicines: an emerging new paradigm. Clinical Pharmacology & Therapeutics, 101, 209–219. doi:10.1002/cpt.557
   PubMed Web of Science ®Google Scholar
• Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. (2018). Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology, 32, 756–769. doi:10.1177/0269881118780612.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., …., Tófoli, L. F. (2018). Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological Medicine, 1, 9.
   Google Scholar
• Planck, M. (1949). Scientific autobiography and other papers, trans. New York: F. Gaynor.
   Google Scholar
• Pollan, M. (2018). How to change your mind: What the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence. New York: Penguin Press.
   Google Scholar
• Richards, W. A. (2015). Sacred knowledge: Psychedelics and religious experiences. New York: Columbia University Press.
   Google Scholar
• Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., … Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of Psychopharmacology, 30, 1165–1180. doi:10.1177/0269881116675512
   PubMed Web of Science ®Google Scholar
• Stone, D. M., Simon, T. R., Fowler, K. A., Kegler, S. R., Yuan, K., Holland, K. M., … Crosby, A. E. (2018). Vital signs: Trends in state suicide rates—United States, 1999–2016 and circumstances contributing to suicide—27 states, 2015. Morbidity and Mortality Weekly Report, 67, 617. doi:10.15585/mmwr.mm6722a1
   PubMed Web of Science ®Google Scholar
• Tupper, K. W., Wood, E., Yensen, R., & Johnson, M. W. (2015). Psychedelic medicine: a re-emerging therapeutic paradigm. Canadian Medical Association Journal, 187, 1054–1059. doi:10.1503/cmaj.141124
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services (2014). The health consequences of smoking—50 years of progress: A report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
   Google Scholar
• World Health Organization (2011). WHO report on the global tobacco epidemic. Geneva: World Health Organization.
   Google Scholar